Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2012
Total Assets: $67.24B
Liabilities Breakdown FY2012
Total Liabilities: $40.51B
Asset Breakdown
Total Assets: $67.24B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.80B | 16.1% |
| Accounts Receivable | $7.61B | 11.3% |
| Inventory | $3.79B | 5.6% |
| Property, Plant & Equipment | $8.06B | 12.0% |
| Goodwill | $15.77B | 23.5% |
| Intangible Assets | $8.59B | 12.8% |
| Other Assets | $12.60B | 18.7% |
Liabilities Breakdown
Total Liabilities: $40.51B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.80B | 4.4% |
| Long-Term Debt | $18.09B | 44.6% |
| Other Liabilities | $20.63B | 50.9% |